Surgical oncology during the post-COVID-19 era: What is next?

Georgios D Lianos; Maximos Frountzas; Dimitrios Schizas; Evangelos G Baltagiannis; George A Alexiou; Christina Bali; Georgios K Glantzounis; Michail Mitsis; Konstantinos Vlachos

doi:10.1002/jso.27104

Surgical oncology during the post-COVID-19 era: What is next?

J Surg Oncol. 2023 Jan;127(1):7-10. doi: 10.1002/jso.27104. Epub 2022 Sep 21.

Authors

Georgios D Lianos¹, Maximos Frountzas², Dimitrios Schizas³, Evangelos G Baltagiannis¹, George A Alexiou⁴, Christina Bali¹, Georgios K Glantzounis¹, Michail Mitsis¹, Konstantinos Vlachos¹

Affiliations

¹ Department of Surgery, School of Health Sciences, University Hospital of Ioannina and Faculty of Medicine, University of Ioannina, Ioannina, Greece.
² First Propaedeutic Department of Surgery, National and Kapodistrian University of Athens, Hippocration General Hospital, Athens, Greece.
³ First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
⁴ Department of Neurosurgery, University Hospital of Ioannina, Ioannina, Greece.

PMID: 36129404
DOI: 10.1002/jso.27104

Abstract

During first outburst of COVID-19, several strategies had been applied for surgical oncology patients to minimize COVID-19 transmission. COVID-19 infection seemed to compromise survival and major complication rates of surgical oncology patients. However, survival, tumor progression and recurrence rates of surgical oncology patients were associated to the consequences of COVID-19 pandemic on their management. In addition, the severity of COVID-19 infections has been downgraded. Therefore, management of surgical oncology patients should be reconsidered.

Keywords: COVID-19; cancer; multidisciplinary; surgical; treatment.

Publication types

Review

MeSH terms

COVID-19* / epidemiology
Humans
Neoplasms* / complications
Pandemics
SARS-CoV-2
Surgical Oncology*